Catalyst Wire Dossier Catalyst Wire Dossier

Sangustop

haemostatic agent · Aesculap AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sangustop, covering 2015-05-28 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-Bound Fibrin Sealant During Liver Resection [Phase 4]

See pricing